Sulfonylureas raise risk of CHD in women. Practitioner 2015; 259 (1779):7

Sulfonylureas raise risk of CHD in women

23 Feb 2015Pais-up subscribers

The use of sulfonylureas in women with type 2 diabetes is associated with a significant increase in the risk of coronary heart disease (CHD), but not stroke, a large prospective cohort study (The Nurses’ Health Study) has shown.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .

To buy this article (£25+tax) copy the article citation above and click Buy article